Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.

NCT01229813 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT01229813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01229813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.
Lead sponsor
Lund University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2013
Enrollment
233 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer